Health ❯ Diseases ❯ Neurological Disorders ❯ Alzheimer's Disease

Treatment Options

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

The verdict raises pressure on UK regulators weighing NHS access.

Lancet Series Calls for Health-System Overhaul to Deliver New Alzheimer’s Blood Tests and Antibody Drugs